Ligand Pharmaceuticals Inc. (LGDN)
Market Closed
3 Jun, 20:00
XFRA 
€
196. 00
+3
+1.55%
€
- Market Cap
23.93 P/E Ratio
- Div Yield
2 Volume
4.45 Eps
€ 193
Previous Close Want to track LGDN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 1.84 | - |
| | | 1.5 | - |
| | | 1.89 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
LGDN Earnings Reports FAQ
What is the earnings per share (EPS) for LGDN?
The current EPS is 4.45.
What is the company's earnings growth rate?
Ligand Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Ligand Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Ligand Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for LGDN at this time, as Ligand Pharmaceuticals Inc has no recent EPS data to calculate it.
